A Cystic Fibrosis drug targeting the basic defect that causes the condition has been shown to be safe and effective in newborns aged four weeks and above, new research involving RCSI University of Medicine and Health Sciences and Children’s Health Ireland has found.
Oregon study finds no clear link between mRNA vaccines and sudden cardiac deaths in young people
Study in Oregon finds no definitive link between mRNA COVID-19 vaccines and sudden cardiac deaths among residents aged 16-30, emphasizing vaccine safety amidst ongoing public
April 16, 2024